Director, MEG Lead Cardiovascular, Medical Evidence Generation

This will be a scientific and strategic leader collaborating across internal functions (Medical Strategy, RWE/Epidemiology, Clinical Operations, Regulatory, HEOR, Access & Value) and with external stakeholders including key opinion leaders (KOLs), academic partners, and data collaborators.

Responsibilities

• Act as a trusted internal advisor to Alliance partners, BMS global and regional Medical Affairs, Clinical Development, Access & Value, Regulatory, and Commercial teams on evidence gaps, opportunities, and study strategy.
• Define and drive the integrated evidence generation strategy (IEP) aligned with Medical Affairs and overall product strategy, spanning clinical trials (Phase II/IV), real-world evidence (RWE), non-interventional studies, registries, observational research, and health outcomes studies.
• Provide hands-on scientific leadership in the design of clinical studies including Phase II/IV trials, Post-marketing commitment studies, Investigator-initiated and collaborative research as applicable.
• Lead or significantly contribute to protocol development as applicable, including Study design, Study objectives and endpoints, Eligibility criteria, Statistical considerations (in collaboration with Biostatistics), Operational feasibility.
• Be accountable for delivering CRCs, ISRs, and MASTs from concept ideation to governance approval and throughout the study lifecycle.
• Serve as a thought leader on evidence generation methodologies to ensure evidence plans are fit-for-purpose and impactful.
• Lead preparation and delivery of evidence generation proposals and updates including results to internal governance bodies and cross-functional stakeholders.
• Apply strong understanding of GCP, ICH guidelines, and clinical trial governance to ensure compliant and high-quality study execution.
• Partner with Clinical Operations and CROs to ensure studies are delivered on time, on budget, and with high data quality.
• Review and interpret clinical and real-world data to ensure medical relevance and scientific integrity.
• Engage with key opinion leaders (KOLs), academic investigators, and external research partners to co-develop high-impact evidence.
• Participate in advisory boards, steering committees, and scientific forums as necessary.
• Collaborate with cross-functional partners to ensure cohesive planning and execution of evidence generation activities across geographies and therapeutic areas.
• Oversee operational delivery of studies, ensuring scientific rigor, quality, compliance (GCP/SOP), timelines, and budgets.
• Contribute to scientific dissemination through publications, abstracts, congress presentations, and advisory boards.
• Contribute to the evolution of MEG therapeutic area strategy and value proposition.

This position is based at Lawrenceville (PPK), or Madison (GIR) New Jersey.

Qualifications & Experience

• Advanced scientific degree (MD, PhD, PharmD, MS or the equivalent) required with extensive, relevant scientific, and/or strong clinical development experience.
• At least 5 years of experience in pharmaceutical clinical development, Medical Affairs, or relevant Commercial experience; previous customer-facing role experience highly desirable.
• Required previous experience in CVRM (Cardiorenal metabolic) TA.
• Deep understanding of clinical research and evidence generation methodologies.
• Strong leadership presence and ability to influence in matrixed environments.
• Demonstrated ability to strategically analyze data generation opportunities with minimal supervision.
• Strategic thinker with strong execution discipline.
• Demonstrated ability to develop and sustain high-performing relationships with external thought leaders and internal matrix stakeholders.
• Adeptness at building credibility with external investigators and collaborative partners competently balancing business and scientific acumen complemented by strong leadership behaviors, authenticity, agility, and an enterprise mindset.
• Understanding of global healthcare systems and academic settings with a demonstrated ability to lead in ambiguous and changing healthcare/business environments.
• Exceptional communication and interpersonal skills to influence decision-making at all levels of the organization.
• Proven experience leading cross-functional study teams and governance interactions.
• Exceptional interpersonal and communication skills appropriately flexing based on audience; expertly leverages effective communication and negotiation skills to influence decisions.
• Expected 20%-30% travel globally.